Serum paraoxonase-1 enzyme activities and oxidative stress levels in patients with esophageal squamous cell carcinoma

References

• Kuwano H, Nakajima M, Miyazaki T, Kato H. Distinctive clinicopathological characteristics in esophageal squamous cell carcinoma. Ann Thorac Cardiovasc Surg 2003;9:6–13.
   PubMedGoogle Scholar
• Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative disease of ageing. Proc Natl Acad Sci USA 1993;90:7915–22.
   PubMed Web of Science ®Google Scholar
• Ames BN, Gold LS, Willet WC. The causes and prevention of cancer. Proc Natl Acad Sci 1995;92:5258–65.0.
   PubMed Web of Science ®Google Scholar
• Giovannucci E, Willet WC. Dietary factors of colon cancer. Ann Med 1994;26:443–52.
   PubMed Web of Science ®Google Scholar
• Batcioglu K, Mehmet N, Ozturk IC, Yilmaz M, Aydogdu N, Erguvan R, et al. Lipid peroxidation and antioxidant status in stomach cancer. Cancer Investigation 2006;24:18–21.
   PubMed Web of Science ®Google Scholar
• Nishikawa M. Reactive oxygen species in tumor metastasis. Cancer Lett 2008;266:53–9.
   PubMed Web of Science ®Google Scholar
• Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem 1997;43:1209–14.
   PubMed Web of Science ®Google Scholar
• Niki E. Lipid peroxidation products as oxidative stress biomarkers. Biofactors 2008;34:171–80.
   PubMed Web of Science ®Google Scholar
• Janssen AM, Bosman CB, van Duijn W, Oostendorp-van de Ruit MM, Kubben FJ, Griffioen G, et al. Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer. Clin Cancer Res 2000;6(8):3183–92.
   PubMed Web of Science ®Google Scholar
• Levy RD, Oosthuizen MM, Degiannis E, Greyling D, Hatzitheofilou C. Glutathione-linked enzymes in benign and malignant oesophageal tissue. Br J Cancer 1999;80:32–7.
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge JMC. Biologically relevant metal ion-dependent hydroxyl radical generation. FEBS Lett 1992;307:108–12.
   PubMed Web of Science ®Google Scholar
• Mackness B, Mackness MI, Arrol S, Turkie W, Durrington PN. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high-density lipoprotein against lowdensity lipoprotein oxidative modification. FEBS Lett 1998;423:57–60.
   PubMed Web of Science ®Google Scholar
• Ayub A, Mackness MI, Arrol S, Mackness B, Patel J, Durrington PN. Serum paraoxonase after myocardial infarction. Arterioscler Thromb Vasc Biol 1999;19:330–5.
   PubMed Web of Science ®Google Scholar
• Elkiran ET, Mar N, Aygen B, Gursu F, Karaoglu A, Koca S. Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population. BMC Cancer 2007;7:48–55.
   PubMed Web of Science ®Google Scholar
• Malik UU, Siddiqui IA, Hashim Z, Zarina S. Measurement of serum paraoxonase activity and MDA concentrations in patients suffering with oral squamous cell carcinoma. Clin Chim Acta 2014;430:38–42.
   PubMed Web of Science ®Google Scholar
• Eroglu M, Yilmaz N, Yalcinkaya S, Ay N, Aydin O, Sezer C. Enhanced HDL-cholesterol-associated anti-oxidant PON-1 activity in prostate cancer patients. Kaohsiung J Med Sci 2013;29(7):368–73.
   PubMed Web of Science ®Google Scholar
• Aydin O, Yacinkaya S, Eren E, Ergin M, Eroglu M, Yilmaz N. Diminished arylesterase enzyme activity and total thiol levels in bladder cancer patients. Clin Lab 2013;59(11–12):1231–7.
   PubMed Web of Science ®Google Scholar
• Akçay MN, Yilmaz I, Polat MF, Akçay G. Serum paraoxonase levels in gastric cancer. Hepatogastroenterology 2003;50:273–5.
   Google Scholar
• Akçay MN, Polat MF, Yilmaz I, Akçay G. Serum paraoxonase levels in pancreatic cancer. Hepatogastroenterology 2003;50:225–7.
   Google Scholar
• Kodydkova J, Vavrova L, Stankova B, Macasek J, Krechler T, Zak A. Antioxidant status and oxidative stress markers in pancreatic cancer and chronic pancreatitis. Pancreas 2013;42(4):614–21.
   PubMed Web of Science ®Google Scholar
• Bulbuller N, Eren E, Ellidag HY, Oner OZ, Sezer C, Aydin O, et al. Diagnostic value of thiols, paraoxonase 1, arylesterase and oxidative balance in colorectal cancer in human. Neoplasma 2013;60(4):419–24.
   PubMed Web of Science ®Google Scholar
• Cayır K, Bilici M, Tekin SB, Kara F, Turkyılmaz A, Yıldınm A. Serum paraoxonase and arylesterase activities in esophageal cancer: a controlled study. Eur J Gen Med 2010;7(4):398–403.
   Google Scholar
• Jass JR, Sobin LH, Watanabe H. The World Health Organization's histologic classification of gastrointestinal tumors. A commentary on the second edition. Cancer 1990;66(10):2162–7
   PubMed Web of Science ®Google Scholar
• Eckerson HW, Wyte MC, La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1983;35:1126–38.
   PubMed Web of Science ®Google Scholar
• Haagen L, Brock A. A new automated method for phenotyping arylesterase (E.C. 3.1.1.2) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clim Biochem 1992;30:391–5.
   PubMedGoogle Scholar
• Yoshioka T, Kawada K, Shimada T, Mori M. Lipid peroxidation in maternal and cord blood and protective mechanisms against activated oxygen toxicity in the blood. Am J Obster Gynecol 1979;135:372–6.
   PubMed Web of Science ®Google Scholar
• McCord JM, Fridovich I. Superoxide dismutase: an enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969;244(22):6049–55.
   PubMed Web of Science ®Google Scholar
• Sonnenwirth AC. Glutathione reductase assay. In: Sonnenwirth AC, Jarett MD, (eds.) Gradwhol's clinical laboratory methods and diagnosis. St. Louis, MO: The CV Mosby Company; 1980;1:854–7.
   Google Scholar
• Popov T, Neikovska L. Metod opredeleniia peroksidznoi aktivnosti krovi [Method of determining the peroxidase activity of blood]. Gig Sanit 1971;36(10):89–91.
   PubMedGoogle Scholar
• Yang J, Lam EW, Hammad HM, Oberley TD, Oberley LW: Antioxidant enzyme levels in oral squamous cell carcinoma and normal human oral epithelium. J Oral Pathol Med 2002;31:71–7.
   PubMed Web of Science ®Google Scholar
• Evans MD, Cooke MS. Factors contributing to the outcome of oxidative damage to nucleic acids. Bioessays 2004;26:533–42.
   PubMed Web of Science ®Google Scholar
• Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994;344:721–4.
   PubMed Web of Science ®Google Scholar
• Hayes JD, McLellan LI. Glutathione and glutathione-dependent enzymes represent a coordinately regulated defence against oxidative stress. Free Radic Res 1999;31:273–300.
   PubMed Web of Science ®Google Scholar
• Taysi S, Uslu C, Akcay F, Sutbeyaz MY. Malondialdehyde and nitric oxide levels in the plasma of patients with advanced laryngeal cancer. Surg Today 2003;33:651–4.
   PubMed Web of Science ®Google Scholar
• Dursun H, Bilici M, Uyanik A, Okcu N, Akyuz M. Antioxidant enzyme activities and lipid peroxidation levels in erythrocytes of patients with oesophageal and gastric cancer. J Int Med Res 2006;34(2):193–9.
   PubMed Web of Science ®Google Scholar
• Arivazhagan S, Kavitha K, Nagini S. Erythrocyte lipid peroxidation and antioxidants in gastric cancer patients. Cell Biochem Funct 1997;15:15–8.
   PubMed Web of Science ®Google Scholar
• Bakan E, Taysi S, Polat MF, Dalga S, Umudum Z, Bakan N, et al. Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer. Jpn J Clin Oncol 2002;32:162–6.
   PubMed Web of Science ®Google Scholar
• Weber WW. Influence of heredity on human sensitivity to environmental chemicals. Environ Mol Mutagen 1995;25:102–14.
   PubMed Web of Science ®Google Scholar
• Kerridge I, Lincz L, Scorgie F, Hickey D, Granter N, Spencer A. Association between xenobiotic gene polymorphisms and non-Hodgkin's lymphoma risk. Br J Haematol 2002;118:477–81.
   PubMed Web of Science ®Google Scholar
• Gerber M, Astre C, Segala C, Saintot M, Scali J, Simony-Lafontaine J, et al. Tumor progression and oxidant-antioxidant status. Cancer Lett 1997;114:211–4.
   PubMed Web of Science ®Google Scholar
• Guven M, Ozturk B, Sayal A, Ozeturk A, Ulutin T. Lipid peroxidation and antioxidant system in the blood of cancerous patients with metastasis. Cancer Biochem Biophys 1999;17:155–62.
   PubMedGoogle Scholar
• Skrzydlewska E, Stankiewicz A, Sulkowska M, Sulkowski S, Kasacka I. Antioxidant status and lipid peroxidation in colorectal cancer. J Toxicol Environ Health A 2001;64:213–22.
   PubMed Web of Science ®Google Scholar
• Gutteridge JM. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995;41:1819–28.
   PubMed Web of Science ®Google Scholar
• Sharma A, Rajjapa M, Saxena A, Sharma M. Antioxidant status in advanced cervical cancer patients undergoing neoadjuvant chemoradiation. Br J Biomed Sci 2007;64:23–7.
   PubMed Web of Science ®Google Scholar
• Oberley TD, Oberley LW. Antioxidant enzyme levels in cancer. Histol Histopathol 1997;12:525–35.
   PubMed Web of Science ®Google Scholar
• Kong Q, Beel JA, Lillehei KO. A threshold concept for cancer therapy. Med Hypotheses 2000;55:29–35.
   PubMed Web of Science ®Google Scholar
• Borek C. Dietary antioxidants and human cancer. Integr Cancer Ther 2004;3:333–41.
   PubMedGoogle Scholar
• Halliwell B. Effect of diet on cancer development: is oxidative DNA damage a biomarker. Free Radic Biol Med 2002;15:968–74.
   Google Scholar
• Mackness B, Durrington PN, Mackness MI: human serum paraoxonase. Gen Pharmacol 1998;31:329–36.
   PubMedGoogle Scholar
• Gan KN, Smolen A, Eckerson HW, La Du BN. Purification of human serum paraoxonase/arylesterase: evidence for one esterase catalyzing both activities. Drug Metab Dispos 1991;19:100–6.
   PubMed Web of Science ®Google Scholar
• Rozenberg O, Rosenblat M, Coleman R, Shih DM, Aviram M. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice. Free Radic Biol Med 2003;34:774–84.
   PubMed Web of Science ®Google Scholar
• Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158–69.
   PubMed Web of Science ®Google Scholar
• Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL, et al. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med 1999;26:892–904.
   PubMed Web of Science ®Google Scholar
• Antognelli C, Mearini L, Talesa VN, Giannantoni A, Mearini E. Association of CYP 17, GSTPI and PON1 polymorphisms with the risk of prostate cancer. Prostate 2005;63:240–51.
   PubMed Web of Science ®Google Scholar
• Saadat M. Paraoxonase 1 genetic polymorphisms and susceptibility to breast cancer: a meta-analysis. Cancer Epidemiol 2012;36:101–3.
   PubMed Web of Science ®Google Scholar
• Marchesani M, Hakkarainen A, Tuomainen TP, Kaikkonen J, Pukkala E, Uimari P, et al. New paraoxonase1 polymorphism II02V and the risk of prostate cancer in Finnish men. J Natl Cancer Inst 2003;95:812–8.
   PubMed Web of Science ®Google Scholar
• Van Der Logt EM, Janssen CH, Van Hooijdonk Z, Roelofs HM, Wobbes T, Nagengast FM, et al. No association between genetic polymorphisms in NAD(P)H oxidase p22phox and paraoxonase 1 and colorectal cancer risk. Anticancer Res 2005;25:1465–70.
   PubMed Web of Science ®Google Scholar
• Vecka M, Jáchymová M, Vávrová L, Kodydková J, Macášek J, Urbánek M, et al. Paraoxonase-1 (PON1) status in pancreatic cancer: relation to clinical parameters. Folia Biol (Praha) 2012;58(6):231–7.
   PubMed Web of Science ®Google Scholar